Cancer biotech Theseus Pharmaceuticals' shares soar in first day of trading
October 07, 2021 at 13:14 PM EDT
Theseus Pharmaceuticals, an OrbiMed spinout that launched publicly just earlier this year, has soared right past its mark in an initial public offering.
